01 10Aimovig
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 378
2019 Revenue in Millions : 306
Growth (%) : 24
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 164
2019 Revenue in Millions : 103
Growth (%) : 59
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 317
2020 Revenue in Millions : 378
Growth (%) : -16
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 215
2020 Revenue in Millions : 164
Growth (%) : 31
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 414
2021 Revenue in Millions : 317
Growth (%) : 31
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 218
2021 Revenue in Millions : 215
Growth (%) : 1
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 266
2022 Revenue in Millions : 218
Growth (%) : 22
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 119
2017 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 306
2018 Revenue in Millions : 119
Growth (%) : 157
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 103
2018 Revenue in Millions : 8
Growth (%) : 1,188
LOOKING FOR A SUPPLIER?